168 related articles for article (PubMed ID: 34582915)
1. Benefit-risk assessment for brincidofovir for the treatment of smallpox: U.S. Food and Drug Administration's Evaluation.
Chan-Tack K; Harrington P; Bensman T; Choi SY; Donaldson E; O'Rear J; McMillan D; Myers L; Seaton M; Ghantous H; Cao Y; Valappil T; Birnkrant D; Struble K
Antiviral Res; 2021 Nov; 195():105182. PubMed ID: 34582915
[TBL] [Abstract][Full Text] [Related]
2. Assessing a drug for an eradicated human disease: US Food and Drug Administration review of tecovirimat for the treatment of smallpox.
Chan-Tack KM; Harrington PR; Choi SY; Myers L; O'Rear J; Seo S; McMillan D; Ghantous H; Birnkrant D; Sherwat AI
Lancet Infect Dis; 2019 Jun; 19(6):e221-e224. PubMed ID: 30853252
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of delayed brincidofovir treatment against a lethal rabbitpox virus challenge in New Zealand White rabbits.
Grossi IM; Foster SA; Gainey MR; Krile RT; Dunn JA; Brundage T; Khouri JM
Antiviral Res; 2017 Jul; 143():278-286. PubMed ID: 28392420
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal Monkeypox Virus Animal Model.
Hutson CL; Kondas AV; Mauldin MR; Doty JB; Grossi IM; Morgan CN; Ostergaard SD; Hughes CM; Nakazawa Y; Kling C; Martin BE; Ellison JA; Carroll DS; Gallardo-Romero NF; Olson VA
mSphere; 2021 Feb; 6(1):. PubMed ID: 33536322
[TBL] [Abstract][Full Text] [Related]
5. In vitro efficacy of brincidofovir against variola virus.
Olson VA; Smith SK; Foster S; Li Y; Lanier ER; Gates I; Trost LC; Damon IK
Antimicrob Agents Chemother; 2014 Sep; 58(9):5570-1. PubMed ID: 24957837
[TBL] [Abstract][Full Text] [Related]
6. The spectre of smallpox lingers.
Nature; 2018 Aug; 560(7718):281. PubMed ID: 30104592
[No Abstract] [Full Text] [Related]
7. The efficacy and pharmacokinetics of brincidofovir for the treatment of lethal rabbitpox virus infection: a model of smallpox disease.
Trost LC; Rose ML; Khouri J; Keilholz L; Long J; Godin SJ; Foster SA
Antiviral Res; 2015 May; 117():115-21. PubMed ID: 25746331
[TBL] [Abstract][Full Text] [Related]
8. Bioterrorism. Blocking smallpox: a second defense.
Cohen J
Science; 2001 Oct; 294(5542):500. PubMed ID: 11641477
[No Abstract] [Full Text] [Related]
9. Brincidofovir: A Novel Agent for the Treatment of Smallpox.
Huston J; Curtis S; Egelund EF
Ann Pharmacother; 2023 Oct; 57(10):1198-1206. PubMed ID: 36688308
[TBL] [Abstract][Full Text] [Related]
10. The Role of Brincidofovir in Preparation for a Potential Smallpox Outbreak.
Foster SA; Parker S; Lanier R
Viruses; 2017 Oct; 9(11):. PubMed ID: 29773767
[TBL] [Abstract][Full Text] [Related]
11. Buccal viral DNA as a trigger for brincidofovir therapy in the mousepox model of smallpox.
Crump R; Korom M; Buller RM; Parker S
Antiviral Res; 2017 Mar; 139():112-116. PubMed ID: 28039021
[TBL] [Abstract][Full Text] [Related]
12. Drug Development against Smallpox: Present and Future.
Delaune D; Iseni F
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31932370
[TBL] [Abstract][Full Text] [Related]
13. The development and approval of tecoviromat (TPOXX
Merchlinsky M; Albright A; Olson V; Schiltz H; Merkeley T; Hughes C; Petersen B; Challberg M
Antiviral Res; 2019 Aug; 168():168-174. PubMed ID: 31181284
[TBL] [Abstract][Full Text] [Related]
14. Smallpox eradication: destruction of variola virus stocks.
Wkly Epidemiol Rec; 2002 Feb; 77(5):34-8. PubMed ID: 11840681
[No Abstract] [Full Text] [Related]
15. Short-term clinical safety profile of brincidofovir: A favorable benefit-risk proposition in the treatment of smallpox.
Chittick G; Morrison M; Brundage T; Nichols WG
Antiviral Res; 2017 Jul; 143():269-277. PubMed ID: 28093339
[TBL] [Abstract][Full Text] [Related]
16. Gearing up for smallpox.
McConnell J
Lancet Infect Dis; 2002 Jul; 2(7):390. PubMed ID: 12127345
[No Abstract] [Full Text] [Related]
17. Oral drug and old vaccine renew smallpox bioterror debate.
Morris K
Lancet Infect Dis; 2002 May; 2(5):262. PubMed ID: 12062979
[No Abstract] [Full Text] [Related]
18. Smallpox: a 21st century killer?
Ratzan SC
J Health Commun; 2003; 8(1):1-3. PubMed ID: 12635807
[No Abstract] [Full Text] [Related]
19. Cidofovir for recurrent respiratory papillomatosis (RRP): a re-assessment of risks.
Derkay C;
Int J Pediatr Otorhinolaryngol; 2005 Nov; 69(11):1465-7. PubMed ID: 16174538
[No Abstract] [Full Text] [Related]
20. Smallpox--eradicated, but a growing terror threat.
Tegnell A; Wahren B; Elgh F
Clin Microbiol Infect; 2002 Aug; 8(8):504-9. PubMed ID: 12197872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
